{"id":232979,"date":"2026-09-07T10:55:55","date_gmt":"2026-09-07T05:25:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=232979"},"modified":"2026-09-07T10:55:55","modified_gmt":"2026-09-07T05:25:55","slug":"why-astal-laboratories-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/","title":{"rendered":"Astal Laboratories (ASTALLTD) Share Price Falls 9.88% Today; Price Action, Valuation and Sector View"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/astalltd\/astal-laboratories-ltd-share-price-today\">Astal Laboratories (ASTALLTD)<\/a>share price fell to Rs 69.3 today, down 9.88% from the previous close. Market cap was Rs 336.81 crore.<\/em><\/div>\n<article>\n<p style=\"margin-top:0!important;\">Astal Laboratories Share Price fell to Rs 69.3 on 07 September 2026, down 9.88% for the day, taking the company\u2019s market capitalisation to Rs 336.81 crore. The Micro Cap pharmaceutical stock opened at Rs 76.9, touched a high of Rs 77.4 and slipped to an intraday low of Rs 62.8, highlighting a sharp same-day re-pricing in today\u2019s trade.<\/p>\n<p>The supplied data confirms the price move but does not establish a company-specific reason behind it. What stands out instead is the contrast between weak one-day price action and a set of fundamentals that look relatively firm on the available numbers. The stock is trading at a P\/E of 34.6 and a P\/B of 1, while ROE is 32.12% and ROCE is 34.78%. That makes today\u2019s decline notable not only because of the size of the move, but also because the stock\u2019s valuation and profitability do not point to a simple, one-line interpretation.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Astal_Laboratories_ASTALLTD_Share_Price_Today_Price_Action_Analysis\" title=\"Astal Laboratories (ASTALLTD) Share Price Today: Price Action Analysis\">Astal Laboratories (ASTALLTD) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Astal_Laboratories_ASTALLTD_Fundamental_Analysis\" title=\"Astal Laboratories (ASTALLTD) Fundamental Analysis\">Astal Laboratories (ASTALLTD) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Astal_Laboratories\" title=\"Why Investors Are Watching Astal Laboratories\">Why Investors Are Watching Astal Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#About_Astal_Laboratories\" title=\"About Astal Laboratories\">About Astal Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Track_Astal_Laboratories_Share_Price_on_Univest\" title=\"Track Astal Laboratories Share Price on Univest\">Track Astal Laboratories Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Why_is_Astal_Laboratories_Share_Price_falling_today\" title=\"Why is Astal Laboratories Share Price falling today?\">Why is Astal Laboratories Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#What_is_Astal_Laboratories_Share_Price_Today\" title=\"What is Astal Laboratories Share Price Today?\">What is Astal Laboratories Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#What_does_todays_price_action_show_for_Astal_Laboratories\" title=\"What does today\u2019s price action show for Astal Laboratories?\">What does today\u2019s price action show for Astal Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#Is_Astal_Laboratories_expensive_based_on_PE_and_PB\" title=\"Is Astal Laboratories expensive based on P\/E and P\/B?\">Is Astal Laboratories expensive based on P\/E and P\/B?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#How_profitable_is_Astal_Laboratories_on_the_supplied_data\" title=\"How profitable is Astal Laboratories on the supplied data?\">How profitable is Astal Laboratories on the supplied data?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#What_is_the_book_value_and_EPS_of_Astal_Laboratories\" title=\"What is the book value and EPS of Astal Laboratories?\">What is the book value and EPS of Astal Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#How_does_Astal_Laboratories_compare_with_pharma_peers\" title=\"How does Astal Laboratories compare with pharma peers?\">How does Astal Laboratories compare with pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#What_sector_does_Astal_Laboratories_belong_to\" title=\"What sector does Astal Laboratories belong to?\">What sector does Astal Laboratories belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-astal-laboratories-share-price-fall-today-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Astal_Laboratories_ASTALLTD_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Astal Laboratories (ASTALLTD) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 69.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 76.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 7.60 (-9.88%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 76.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 77.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 62.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.11 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 336.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Astal Laboratories Share Price Today showed a sharp downward session. The stock moved from the previous close of Rs 76.9 to Rs 69.3, a decline of Rs 7.6 or 9.88%. It opened flat at Rs 76.9, briefly touched Rs 77.4, then fell to Rs 62.8 before recovering some ground into the latest quoted level.<\/p>\n<p>The intraday range of Rs 14.6 was wide relative to the stock price, which signals elevated volatility through the session. Turnover was Rs 0.11 crore. For a Micro Cap name, that combination of a broad range and a steep close-to-close decline is usually enough to draw market attention even when the available dataset does not attach a specific trigger.<\/p>\n<p>Technical markers add more context. The RSI stands at 46.87, which places momentum in a neutral-to-soft zone rather than at an extreme. The stock is also below its 50-day moving average of Rs 81.93 and its 200-day moving average of Rs 78.59. That indicates the current price is sitting under both medium-term and longer-term reference levels based on the supplied data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astal_Laboratories_ASTALLTD_Fundamental_Analysis\"><\/span><strong>Astal Laboratories (ASTALLTD) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 336.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">34.6x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.12%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">34.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.22<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 76.99<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On fundamentals, the picture is mixed but interesting. Astal Laboratories is a Micro Cap company with a market value of Rs 336.81 crore. The stock trades at 34.6 times earnings and 1 time book value. A P\/E at this level is not especially low, but the P\/B ratio suggests the market is valuing the company close to its stated net worth.<\/p>\n<p>Profitability metrics are stronger than the balance-sheet multiple alone might imply. ROE stands at 32.12% and ROCE at 34.78%, both high in absolute terms on the supplied numbers. EPS is Rs 2.22, while book value per share is Rs 76.99, above the current price of Rs 69.3. Dividend yield is listed at 0%, so there is no dividend support reflected in this dataset.<\/p>\n<p>That leaves investors with a stock where one-day price weakness sits beside high return ratios and a low P\/B reading. It does not automatically make the stock cheap or expensive; instead, it points to the need for wider industry comparison before drawing conclusions from the headline decline alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">34.6x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.2x to 659.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.12%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">34.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 336.81 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 674.09 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,840.86 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Astal Laboratories operates in Healthcare, specifically Pharmaceuticals &amp; Drugs. In the same-industry benchmark of 204 companies, its P\/E of 34.6 is slightly above the median of 32.83 and below the average of 48.79. That places the stock near the middle of the industry valuation distribution, not at an extreme.<\/p>\n<p>The P\/B comparison is different. At 1, the company\u2019s price-to-book ratio is below the industry median of 2.92 and average of 4.34. Profitability is stronger than benchmark norms: ROE of 32.12% is above the median of 11.78% and average of 10.63, while ROCE of 34.78% is above the median of 13.65% and average of 13.19.<\/p>\n<p>Size, however, remains small relative to the group. Astal Laboratories\u2019 market capitalisation of Rs 336.81 crore is below the benchmark median of Rs 674.09 crore and far below the benchmark average of Rs 13,840.86 crore. So the sector view is of a much smaller company with above-benchmark return ratios, a below-benchmark P\/B, and a P\/E that is only modestly above the median.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,55,633.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,41,576.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">82.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,84,478.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,888.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,820.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Compared with larger listed pharma companies, Astal Laboratories is much smaller by market value. Its Rs 336.81 crore market cap is far below Sun Pharmaceutical Industries, Divi&#8217;s Laboratories, Torrent Pharmaceuticals, Cipla and Zydus Lifesciences, each of which is above Rs 1,11,000 crore in the supplied peer set.<\/p>\n<p>On valuation, the company\u2019s P\/E of 34.6 is below Sun Pharma\u2019s 37.67, far below Divi\u2019s 82.59 and Torrent\u2019s 84.58, slightly above Cipla\u2019s 33.19, and above Zydus Lifesciences\u2019 24.78. The P\/B ratio of 1 is lower than all five peers, whose P\/B values range from 3.18 to 20.55.<\/p>\n<p>Return ratios are the most notable area of contrast. ROE of 32.12% is above all five named peers, and ROCE of 34.78% is also above each of them on the provided figures. That does not explain today\u2019s decline, but it does show why the stock may remain under watch despite the day\u2019s weakness.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Astal_Laboratories\"><\/span><strong>Why Investors Are Watching Astal Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock fell 9.88% in a single session to Rs 69.3.<\/li>\n<li>The intraday swing was sharp, with a high of Rs 77.4 and a low of Rs 62.8.<\/li>\n<li>RSI is 46.87, while the price is below both the 50 DMA of Rs 81.93 and the 200 DMA of Rs 78.59.<\/li>\n<li>P\/B of 1 is below industry median levels, while P\/E of 34.6 is only slightly above the industry median.<\/li>\n<li>ROE and ROCE are well above industry median and average values in the supplied benchmark set.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Astal_Laboratories\"><\/span><strong>About Astal Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astal Laboratories is part of the Healthcare sector and operates in the Pharmaceuticals &amp; Drugs industry. Based on the supplied data, it is being assessed against a wide set of same-industry companies on valuation, profitability and size. That context matters because today\u2019s move is happening in a smaller listed pharma name whose return ratios compare strongly on the available figures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Astal_Laboratories_Share_Price_on_Univest\"><\/span><strong>Track Astal Laboratories Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use<a href=\"https:\/\/univest.in\/stocks\/astalltd\/astal-laboratories-ltd-share-price-today\">Astal Laboratories (ASTALLTD) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Investors can track Astal Laboratories Share Price on Univest for live price moves, valuation ratios, technical levels, peer comparison and broader market context. That helps place the current decline in a framework built on actual market data rather than speculation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Astal_Laboratories_Share_Price_falling_today\"><\/span><strong>Why is Astal Laboratories Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The supplied data confirms that the stock fell 9.88% to Rs 69.3 today. However, the dataset does not establish any company-specific catalyst, so the verified takeaway is the price event itself and the wide intraday range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Astal_Laboratories_Share_Price_Today\"><\/span><strong>What is Astal Laboratories Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Astal Laboratories Share Price Today is Rs 69.3. The stock was down Rs 7.6 from the previous close of Rs 76.9, representing a single-day decline of 9.88% as of the supplied market update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Astal_Laboratories\"><\/span><strong>What does today\u2019s price action show for Astal Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Today\u2019s price action shows a flat open at Rs 76.9, a high of Rs 77.4 and a low of Rs 62.8 before the stock settled at Rs 69.3. That points to a volatile session with clear downward pressure and some.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Astal_Laboratories_expensive_based_on_PE_and_PB\"><\/span><strong>Is Astal Laboratories expensive based on P\/E and P\/B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The stock trades at a P\/E of 34.6 and a P\/B of 1. Its P\/E is slightly above the industry median of 32.83, while its P\/B is below the industry median of 2.92, giving a mixed valuation picture on the.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Astal_Laboratories_on_the_supplied_data\"><\/span><strong>How profitable is Astal Laboratories on the supplied data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The company shows ROE of 32.12% and ROCE of 34.78%, both above the Pharmaceuticals &amp; Drugs industry medians of 11.78% and 13.65. On the available numbers, profitability metrics are notably stronger than benchmark norms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_book_value_and_EPS_of_Astal_Laboratories\"><\/span><strong>What is the book value and EPS of Astal Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Astal Laboratories has an EPS of Rs 2.22 and a book value per share of Rs 76.99. With the current price at Rs 69.3, the stock is trading below its stated book value in the supplied dataset.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astal_Laboratories_compare_with_pharma_peers\"><\/span><strong>How does Astal Laboratories compare with pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Astal Laboratories is far smaller by market cap than peers such as Sun Pharma, Divi\u2019s, Torrent, Cipla and Zydus. However, its ROE of 32.12% and ROCE of 34.78% are higher than each of those supplied peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Astal_Laboratories_belong_to\"><\/span><strong>What sector does Astal Laboratories belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Astal Laboratories belongs to the Healthcare sector and operates in the Pharmaceuticals &amp; Drugs industry. The benchmark comparison in the supplied data covers 204 same-industry companies. The stock belongs to the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors may watch whether the stock stabilises after today\u2019s 9.88% decline, how it trades relative to the 50 DMA of Rs 81.93 and the 200 DMA of Rs 78.59, and whether valuation continues to look different from sector averages on.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astal Laboratories Share Price falls to Rs 69.3. marking a 9.88% fall today. Market cap stands at Rs 336.81 crore.<\/p>\n","protected":false},"author":29,"featured_media":232978,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-232979","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["232978"],"rank_math_title":["Astal Laboratories Share Price Today: 9.88% Decline"],"rank_math_description":["Astal Laboratories Share Price fell 9.88% to Rs 69.3. Read price action, valuation, fundamentals, sector comparison and peer analysis today."],"rank_math_focus_keyword":["Astal Laboratories Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Astal_Laboratories_ASTALLTD_Share_Price_Falls_988_Today_Price_Action_Valuation_and_Sector_View_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/232979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=232979"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/232979\/revisions"}],"predecessor-version":[{"id":232980,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/232979\/revisions\/232980"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/232978"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=232979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=232979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=232979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}